Return to Previous Page

Understanding novel features of KRAS biology to discover new therapeutic vulnerabilities

When

Friday, July 19, 2019

10:00 AM - 11:00 AM

Where

ATRF, ATRF Auditorium

Questions?

Morgan Covert 301-846-6790

Event Type

Seminar

Event Series

CRTP Seminar Series

Event Description

Chiara Ambrogio, PhD, investigates the KRAS signaling pathway in both normal and pathophysiologic states, to aid in developing new therapeutic strategies. Using isogenic cell lines of mouse and human origin expressing different KRAS oncogenic mutations, she characterizes novel compounds for the direct inhibition of KRAS in lung cancer.

Featured Speaker(s)

Dr. Chiara Ambrogio PhD Janne Lab, Harvard
Close